Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 132

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Neuronal impact of patient-specific aberrant NRXN1α splicing

Flaherty, Erin, Zhu, Shijia, Barretto, Natalie, Cheng, Esther, Deans, P. J. Michael, Fernando, Michael B., Schrode, Nadine, Francoeur, Nancy, Antoine, Alesia, Alganem, Khaled, Halpern, Madeline, Deikus, Gintaras, Shah, Hardik, Fitzgerald, Megan, Ladran, Ian, Gochman, Peter, Rapoport, Judith, Tsankova, Nadejda M., McCullumsmith, Robert, Hoffman, Gabriel E., Sebra, Robert, Fang, Gang, Brennand, Kristen J.·2019·Nature Genetics
DOI 10.1038/s41588-019-0539-zPMC PMC7451045
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-019-0539-z

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Ching, M. S. L. et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am. J. Med. Genet. B 153, 937–947 (2010). · DOI
  2. Matsunami, N. et al. Identification of rare recurrent copy number variants in high-risk autism families and their prevalence in a large ASD population. PLoS ONE 8, e52239 (2013). · DOI
  3. Moller, R. S. et al. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia 54, 256–264 (2013). · DOI
  4. Lowther, C. et al. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Genet. Med. 19, 53–61 (2017). · DOI
  5. Grayton, H. M., Missler, M., Collier, D. A. & Fernandes, C. Altered social behaviours in Neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS ONE 8, e67114 (2013). · DOI · Paper page
  6. Pak, C. et al. Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1. Cell Stem Cell 17, 316–328 (2015). · DOI · Paper page
  7. Jenkins, A. K. et al. Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging. Mol. Psychiatry 21, 701–706 (2016). · DOI
  8. Harkin, L. F. et al. Neurexins 1–3 each have a distinct pattern of expression in the early developing human cerebral cortex. Cereb. Cortex 27, 1–17 (2016).
  9. Schreiner, D. et al. Targeted combinatorial alternative splicing generates brain region-specific repertoires of neurexins. Neuron 84, 386–398 (2014). · DOI
  10. Nguyen, T.-M. et al. An alternative splicing switch shapes neurexin repertoires in principal neurons versus interneurons in the mouse hippocampus. eLife 5, e22757 (2016). · DOI
  11. Fuccillo, M. V. et al. Single-cell mRNA profiling reveals cell-type-specific expression of neurexin isoforms. Neuron 87, 326–340 (2015). · DOI
  12. Traunmuller, L., Gomez, A. M., Nguyen, T.-M. & Scheiffele, P. Control of neuronal synapse specification by a highly dedicated alternative splicing program. Science 352, 982–986 (2016). · DOI · Paper page
  13. Ahn, K., An, S. S., Shugart, Y. Y. & Rapoport, J. L. Common polygenic variation and risk for childhood-onset schizophrenia. Mol. Psychiatry 21, 94–96 (2016). · DOI
  14. Ahn, K. et al. High rate of disease-related copy number variations in childhood onset schizophrenia. Mol. Psychiatry 19, 568–572 (2014). · DOI
  15. Sudhof, T. C. Synaptic neurexin complexes: a molecular code for the logic of neural circuits. Cell 171, 745–769 (2017). · DOI · Paper page
  16. Brennand, K. et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20, 361–368 (2014). · DOI · Paper page
  17. Hoffman, G. E. et al. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains. Nat. Commun. 8, 2225 (2017). · DOI
  18. Ho, S., Topol, A. & Brennand, K. J. From ‘directed differentiation’ to ‘neuronal induction’: modeling neuropsychiatric disease. Biomark. Insights 10, 31 (2015).
  19. Ballouz, S. & Gillis, J. Strength of functional signature correlates with effect size in autism. Genome Med. 9, 64 (2017). · DOI
  20. Sanders, S. J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215–1233 (2015). · DOI · Paper page
  21. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016). · DOI · Paper page
  22. Steijger, T. et al. Assessment of transcript reconstruction methods for RNA-seq. Nat. Methods 10, 1177–1184 (2013). · DOI · Paper page
  23. Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785–798 (2013). · DOI · Paper page
  24. Ho, S. M. et al. Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells. Methods 101, 113–124 (2016). · DOI · Paper page
  25. Aoto, J., Martinelli, D. C., Malenka, R. C., Tabuchi, K. & Südhof, T. C. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 154, 75–88 (2013). · DOI
  26. Aoto, J., Földy, C., Ilcus, S. M. C., Tabuchi, K. & Südhof, T. C. Distinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses. Nat. Neurosci. 18, 997–1007 (2015). · DOI
  27. Graf, E. R., Zhang, X., Jin, S.-X. X., Linhoff, M. W. & Craig, A. M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119, 1013–1026 (2004). · DOI
  28. Uemura, T. et al. Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 141, 1068–1079 (2010). · DOI · Paper page
  29. Pettem, K. L. et al. The specific alpha-neurexin interactor calsyntenin-3 promotes excitatory and inhibitory synapse development. Neuron 80, 113–128 (2013). · DOI
  30. Linhoff, M. W. et al. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61, 734–749 (2009). · DOI
  31. Anderson, G. R. et al. beta-neurexins control neural circuits by regulating synaptic endocannabinoid signaling. Cell 162, 593–606 (2015). · DOI
  32. Quinn, D. P. et al. Pan-neurexin perturbation results in compromised synapse stability and a reduction in readily releasable synaptic vesicle pool size. Sci. Rep. 7, 42920 (2017). · DOI
  33. Mountoufaris, G., Canzio, D., Nwakeze, C. L., Chen, W. V. & Maniatis, T. Writing, reading, and translating the clustered protocadherin cell surface recognition code for neural circuit assembly. Annu. Rev. Cell Dev. Biol. 34, 471–493 (2018). · DOI
  34. Ding, X. et al. Activity-induced histone modifications govern Neurexin-1 mRNA splicing and memory preservation. Nat. Neurosci. 20, 690–699 (2017). · DOI
  35. Rozic, G., Lupowitz, Z., Piontkewitz, Y. & Zisapel, N. Dynamic changes in neurexins’ alternative splicing: Role of rho-associated protein kinases and relevance to memory formation. PLoS ONE 6, e18579 (2011). · DOI
  36. Boucard, A. A., Chubykin, A. A., Comoletti, D., Taylor, P. & Sudhof, T. C. A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48, 229–236 (2005). · DOI · Paper page
  37. Ko, J., Fuccillo, M. V., Malenka, R. C. & Südhof, T. C. LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 64, 791–798 (2009). · DOI
  38. Siddiqui, T. J., Pancaroglu, R., Kang, Y., Rooyakkers, A. & Craig, A. M. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J. Neurosci. 30, 7495–7506 (2010). · DOI
  39. Boucard, Aa, Ko, J. & Südhof, T. C. High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J. Biol. Chem. 287, 9399–9413 (2012). · DOI
  40. Zhao, D. et al. MicroRNA profiling of neurons generated using induced pluripotent stem cells derived from patients with schizophrenia and schizoaffective disorder, and 22q11.2 Del. PLoS ONE 10, e0132387 (2015). · DOI
  41. Marchetto, M. C. N. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527–539 (2010). · DOI · Paper page
  42. Krey, J. F. et al. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 16, 201–209 (2013). · DOI
  43. Yeh, E. et al. Patient-derived iPSCs show premature neural differentiation and neuron type-specific phenotypes relevant to neurodevelopment. Mol. Psychiatry 23, 1687–1698 (2018). · DOI
  44. Chen, S. X., Tari, P. K., She, K. & Haas, K. Neurexin–neuroligin cell adhesion complexes contribute to synaptotropic dendritogenesis via growth stabilization mechanisms in vivo. Neuron 67, 967–983 (2010). · DOI
  45. Roussos, P. et al. A role for noncoding variation in schizophrenia. Cell Rep. 9, 1417–1429 (2014). · DOI · Paper page
  46. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013). · DOI · Paper page
  47. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014). · DOI · Paper page
  48. Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics 17, 483 (2016). · DOI · Paper page
  49. Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453–457 (2015). · DOI · Paper page
  50. Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015). · DOI · Paper page
  51. Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016). · DOI · Paper page
  52. Chen, L. & Zheng, S. Studying alternative splicing regulatory networks through partial correlation analysis. Genome Biol. 10, R3 (2009). · DOI
  53. Zhu, S., Wang, G., Liu, B. & Wang, Y. Modeling exon expression using histone modifications. PLoS ONE 8, e67448 (2013). · DOI
  54. Wang, L., Feng, Z., Wang, X., Wang, X. & Zhang, X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26, 136–138 (2010). · DOI · Paper page
  55. Dorsett, C. R. et al. Traumatic brain injury induces alterations in cortical glutamate uptake without a reduction in glutamate transporter-1 protein expression. J. Neurotrauma 34, 220–234 (2017). · DOI
  56. Mcguire, J. L. et al. Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr. 3, 30 (2017). · DOI
  57. Appuhamy, J. A. et al. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells. J. Dairy Sci. 97, 419–429 (2013). · DOI

Cited by

See all 132

Metadata

Authors
Flaherty, E., Zhu, S., Barretto, N., Cheng, E., Deans, P. J. M., Fernando, M. B., Schrode, N., Francoeur, N., Antoine, A., Alganem, K., Halpern, M., Deikus, G., Shah, H., Fitzgerald, M., Ladran, I., Gochman, P., Rapoport, J., Tsankova, N. M., McCullumsmith, R., Hoffman, G. E., Sebra, R., Fang, G., & Brennand, K. J.
Venue
Nature Genetics
Publisher
Springer Science and Business Media LLC
Published
2019-11-29
Volume
51
Issue
12
Pages
1679-1690
ISSN
  • 1061-4036
  • 1546-1718
DOI
10.1038/s41588-019-0539-z
PMC
PMC7451045
Cited by
132
References
26
Language
en
Licence
Funders
  • Brain and Behavior Research Foundation
  • New York Stem Cell Foundation
  • U.S. Department of Health & Human Services | National Institutes of Health (MH101454, MH106056, MH112285, MH107487)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.